Skip to main content

Table 2 Circulating tumor cell analysis in NSCLC and SCLC patients

From: Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

    Number of CTCs/ mL
Patient # Diagnosis Histology, stage, disease site Unicapture Quadcapture
001 NSCLC Adenocarcinoma, IV; bone 0 0
002 NSCLC Adenocarcinoma, IV; bone 0 0
003 NSCLC Adenocarcinoma, IV; brain 0 1
004 NSCLC Adenocarcinoma, IV; bone 0 0
006 NSCLC Adenocarcinoma, II; lymph nodes 0 1
007 NSCLC Squamous, IV; brain metastasis 0 0
008 NSCLC Adenocarcinoma, IV; lymph node metastasis 84 0
010 NSCLC Adenocarcinoma, IV; brain, bone, adrenal, subcutaneous tissue 1 0
011 NSCLC Adenocarcinoma, IV; adrenal 1 0
012 NSCLC Adenocarcinoma, IV; liver 1 0
005 SCLC Extensive; liver 1 1
009 SCLC Extensive; liver, adrenal, bone 1615 1491
013 SCLC Extensive; lymph nodes 84 62
014 SCLC Extensive; bone, liver, brain 121 112
015 SCLC Extensive; bone 0 0
016 SCLC Limited stage 0 2
018 SCLC Limited stage 0 0
019 SCLC Extensive; liver 4007 3810
020 SCLC Limited stage 0 6
021 SCLC Extensive 22 16
\